Overview of chemotherapy goals: cure, palliation, and adjuvant therapy, highlighting the challenges of selectivity.

Detailed look at the systemic toxicities affecting rapidly dividing cells, including bone marrow and gastrointestinal effects.

Mechanism of action for alkylating agents and platinum complexes, focusing on DNA cross-linking.

Comparing folate, purine, and pyrimidine antagonists and their specific enzymatic targets.

Explaining how natural products disrupt microtubule dynamics and topoisomerase function.

The cardiotoxicity of anthracyclines and the role of hormonal therapy in managing dependent cancers.

The shift toward precision oncology using kinase inhibitors and monoclonal antibodies.

Analysis of cell cycle specificity and the fractional kill hypothesis in treatment design.

The pharmacological basis for multi-drug regimens to overcome resistance and maximize cell kill.